You are here: Home » News-CM » Companies » Results
Business Standard

Biofil Chemicals & Pharmaceuticals standalone net profit declines 74.07% in the September 2017 quarter

Capital Market 

Sales decline 71.58% to Rs 0.83 crore

Net profit of & Pharmaceuticals declined 74.07% to Rs 0.07 crore in the quarter ended September 2017 as against Rs 0.27 crore during the previous quarter ended September 2016. Sales declined 71.58% to Rs 0.83 crore in the quarter ended September 2017 as against Rs 2.92 crore during the previous quarter ended September 2016. ParticularsQuarter EndedSep. 2017Sep. 2016% Var.Sales0.832.92 -72 OPM %20.4811.99 -PBDT0.140.34 -59 PBT0.070.27 -74 NP0.070.27 -74

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Wed, November 15 2017. 17:32 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU